Tuulia’s primary scientific background is how to apply nuclear imaging solutions in drug development related to CNS and oncological research. Besides imaging, she has wide scientific experience in disease models and ex vivo biomolecule analysis. In 2011 she joined to CR and established nuclear imaging unit. Within these years the group grew both in personnel number and scientific comprehensiveness, 2017 the team was merged with previous Biomarker team. In addition to science, she has key role in client services, multi-site project coordination as well laboratory management and leadership. She received her MSc and PhD in the University of Eastern Finland, specialized in bioscientific chemistry.